Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Atherosclerosis|July 16, 2003
Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphismJeffrey S Cohn, Michel Tremblay, Lucie Boulet, et al.The Canadian Journal of Cardiology|June 8, 2013
Regional distribution and metabolic effect of PCSK9 insLEU and R46L gene mutations and apoE genotypeZuhier Awan, Edgard E Delvin, Emile Levy, et al.Clinical Chemistry|July 25, 2009
Plasma PCSK9 is associated with age, sex, and multiple metabolic markers in a population-based sample of children and adolescentsAlexis Baass, Geneviève Dubuc, Michel Tremblay, et al.Atherosclerosis|October 19, 2004
Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemiaJeffrey S Cohn, Michel Tremblay, Rami Batal, et al.Journal of Lipid Research|July 18, 2003
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolismJeffrey S Cohn, Rami Batal, Michel Tremblay, et al.FEBS Letters|May 20, 2009
Apolipoprotein E limits oxidative stress-induced cell dysfunctions in human adipocytesEvelyne Tarnus, Hanny Wassef, Jean-François Carmel, et al.Clinical Biochemistry|April 12, 2014
The effect of insulin on circulating PCSK9 in postmenopausal obese womenZuhier Awan, Geneviève Dubuc, May Faraj, et al.The Journal of Laboratory and Clinical Medicine|January 9, 2003
Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in healthAlain Piolot, Denis Blache, Lucie Boulet, et al.Journal of Lipid Research|October 5, 2002
Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjectsJeffrey S Cohn, Michel Tremblay, Rami Batal, et al.Lipids in Health and Disease|May 14, 2013
Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populationsJanice Mayne, Teik Chye Ooi, Angela Raymond, et al.Pageof 6